All Articles in Group
On December 7, 2000, Thales was born. This transformation of the company was much more than an extraordinary communication operation. The adoption of the Thales name was an important milestone in the history of the Group, symbolising its remarkable ability to always ant
Thales has rapidly deployed innovative solutions to serve the healthcare providers and other public organisations who are addressing the most critical challenges in the fight against COVID-19 all around the world. To support frontline medical teams in their missions, Th
Thales (Euronext Paris: HO) announces today its order intake and sales for the first quarter of 2020.
[Update Monday 23 March 2020] Covid-19 has been declared a pandemic by the World Health Organisation. Our first thoughts are with all those who have been affected by this virus, and we are truly thankful to the health workers and other professionals who are fighting to
Thales (Euronext Paris: HO) announces the implementation of a global adaptation plan in response to the Covid-19 pandemic.
Thales’s Board of Directors (Euronext Paris: HO) met on 25 February 2020 to review the 2019 financial statements.
• Order intake: €10.4 billion, up 10% (-6% on an organic basis ) • Sales: €12.4 billion, up 14.1% (+0.0% on an organic basis)
Thales adjusts down its 2019 organic sales growth target and confirms its other short and medium-term financial targets
• Q3 2019 sales in line with consensus expectations: €4.2 billion, up 23.4% (+0.9% on an organic basis ) • 2019 sales growth target adjusted: growth now expected around +1% • Confirmation of all other 2019 financial objectives (order intake and EBIT ), as well as medium
• Euronext's Index Steering Committee, which meets four times a year to validate the list of 40 stocks making up the CAC40, has decided today to include Thales in the benchmark French stock market index. • Thales will be included in the CAC40 from June 21st 2019 a
• Solid order intake: €2.3 billion, up 4% excluding impact of OneSKY jumbo order in Australia, worth €855m (down 25% on a reported basis) • Sales: €3.4 billion, down 2.0% on an organic basis (down 1.5% on a reported basis) • All financial objectives confirmed